|
BE580490A
(fr)
|
1958-07-15 |
1960-01-08 |
Merck & Co Inc |
Compositions et procédés pour abaisser la teneur en cholestérol du sang
|
|
US3383281A
(en)
|
1961-09-22 |
1968-05-14 |
Merck & Co Inc |
Method for binding bile acids in vivo
|
|
US3308020A
(en)
|
1961-09-22 |
1967-03-07 |
Merck & Co Inc |
Compositions and method for binding bile acids in vivo including hypocholesteremics
|
|
US3287370A
(en)
|
1965-06-08 |
1966-11-22 |
Mcneilab Inc |
Tetrahydrobenzothiepins
|
|
US3389144A
(en)
|
1965-06-08 |
1968-06-18 |
Mcneilab Inc |
5-pyridyl-2, 3, 4, 5-tetrahydrobenzothiepin-5-ols
|
|
DE1593760A1
(de)
|
1967-02-01 |
1972-06-08 |
Boehringer Sohn Ingelheim |
Verfahren zur Herstellung neuer Benz-epinderivate
|
|
US3444176A
(en)
|
1967-04-28 |
1969-05-13 |
Mcneilab Inc |
Certain 4-diloweralkylamino-lower alkyl - 5 - pyridyl (or phenyl)-2,3-dihydro - 1 - benzothiepins and derivatives thereof
|
|
GB1269551A
(en)
|
1969-03-27 |
1972-04-06 |
Science Union & Cie |
New tricyclic derivatives and process for their manufacture
|
|
NL7017227A
(enExample)
|
1969-12-27 |
1971-06-29 |
|
|
|
US3694446A
(en)
|
1970-02-24 |
1972-09-26 |
William J Houlihan |
5-(substituted-benzyl)-benzocycloheptenes and-1-benzthiepines
|
|
CH531000A
(de)
|
1970-03-11 |
1972-11-30 |
Sandoz Ag |
Verfahren zur Herstellung neuer Benzocycloheptathiophene
|
|
CH537404A
(de)
|
1970-09-24 |
1973-05-31 |
Sandoz Ag |
Verfahren zur Herstellung neuer Thiophenderivate
|
|
US3821249A
(en)
|
1970-03-13 |
1974-06-28 |
En Nom Collectif Science Union |
Dibenzothiazefin derivatives
|
|
US3758528A
(en)
|
1970-03-13 |
1973-09-11 |
Science Union & Cie |
Tricyclic compounds
|
|
GB1348642A
(en)
|
1970-10-15 |
1974-03-20 |
Howard A N |
Hypocholesterolaemic compositions
|
|
US3769399A
(en)
|
1971-03-05 |
1973-10-30 |
L Hagerman |
Intestinal bile acid binding process and compositions
|
|
JPS4711953U
(enExample)
|
1971-03-08 |
1972-10-12 |
|
|
|
GB1428110A
(en)
|
1972-05-30 |
1976-03-17 |
Reckitt & Colmann Prod Ltd |
Pharmaceutical antihypertensive and vasodilator compositions
|
|
US3974272A
(en)
|
1972-09-01 |
1976-08-10 |
Merck & Co., Inc. |
Palatable cholestyramine coacervate compositions
|
|
CH582699A5
(enExample)
|
1973-03-26 |
1976-12-15 |
Sandoz Ag |
|
|
US3954764A
(en)
|
1973-03-30 |
1976-05-04 |
Hoffmann-La Roche Inc. |
Dibenzo [b,f]thiepins bearing piperazinyl substitution
|
|
CH593970A5
(en)
|
1973-03-30 |
1977-12-30 |
Hoffmann La Roche |
10-(4-Substd. piperazino) dibenzo (b,f) thiepins - CNS depressants without cataleptic side-effects
|
|
US4044010A
(en)
|
1973-03-30 |
1977-08-23 |
Hoffmann-La Roche Inc. |
Dibenzo[b,f] thiepins bearing piperazinyl substitution
|
|
US3928383A
(en)
|
1973-06-08 |
1975-12-23 |
Hoffmann La Roche |
Propynylamine-substituted dibenzo{8 b,f{9 thiepins and dibenz{8 b,f{9 oxepins
|
|
SE7504508L
(sv)
|
1974-05-10 |
1975-11-11 |
Ciba Geigy Ag |
Nya heterocykliska s-imino-s-oxider.
|
|
SE420725B
(sv)
|
1974-09-26 |
1981-10-26 |
Ciba Geigy Ag |
Sett att framstella 2,3-dihydro-1-benstiepin-4-karboxylsyraamider
|
|
US4252790A
(en)
|
1974-10-23 |
1981-02-24 |
Interx Research Corporation |
Method for treating gastric ulcer-prone patients
|
|
GB1566609A
(en)
|
1977-03-10 |
1980-05-08 |
Reckitt & Colmann Prod Ltd |
Pharmaceutical compositions containing cholestyramine and alginic acid
|
|
US4153612A
(en)
|
1977-10-31 |
1979-05-08 |
The Upjohn Company |
2-Benzoxepins
|
|
US4251526A
(en)
|
1977-10-31 |
1981-02-17 |
Mccall John M |
2-Benzothiepins and compositions and methods of use therefore
|
|
US4207239A
(en)
|
1977-10-31 |
1980-06-10 |
The Upjohn Company |
Benzothiepins
|
|
US4247533A
(en)
|
1978-05-01 |
1981-01-27 |
The Rockefeller University |
Hemoglobin A1c radioimmunoassay
|
|
IT1106718B
(it)
|
1978-12-21 |
1985-11-18 |
Alfa Farmaceutici Spa |
Composizioni a base di resine anioniche salificate farmacologicamente attive
|
|
US5169857A
(en)
|
1988-01-20 |
1992-12-08 |
Bayer Aktiengesellschaft |
7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis
|
|
AU548253B2
(en)
|
1981-05-11 |
1985-12-05 |
Pierre Fabre S.A. |
Benzoxepine derivatives and sulphur and nitrogen analogues thereof
|
|
US4647459A
(en)
|
1983-07-20 |
1987-03-03 |
Warner-Lambert Company |
Confectionery compositions containing magnesium trisilicate adsorbates
|
|
ES8705837A1
(es)
|
1985-01-10 |
1987-05-16 |
Tanabe Seiyaku Co |
Un procedimiento para la preparacion de derivados de naftaleno.
|
|
AU597671B2
(en)
|
1986-06-20 |
1990-06-07 |
Suntory Limited |
2-Phenylbenzoxepin derivative
|
|
JPS6310746A
(ja)
|
1986-07-01 |
1988-01-18 |
Tanabe Seiyaku Co Ltd |
ナフタレン誘導体
|
|
US4895723A
(en)
|
1986-09-08 |
1990-01-23 |
Amer And Company |
Cholestyramine compositions and method for preparation thereof
|
|
US4814354A
(en)
|
1986-09-26 |
1989-03-21 |
Warner-Lambert Company |
Lipid regulating agents
|
|
ZA876930B
(en)
|
1986-10-07 |
1988-05-25 |
Hoffmann La Roche |
Pharmaceutical compositions
|
|
US5164387A
(en)
|
1988-07-14 |
1992-11-17 |
Hoffmann-Laroche Inc. |
Condensed heterocyclic compounds
|
|
AU626881B2
(en)
|
1988-07-14 |
1992-08-13 |
F. Hoffmann-La Roche Ag |
Benzofused heterocyclics used as pharmaceuticals
|
|
US5158943A
(en)
|
1988-11-21 |
1992-10-27 |
Takeda Chemical Industries, Ltd. |
Sulfur-containing heterocyclic compounds
|
|
US4874744A
(en)
|
1989-03-13 |
1989-10-17 |
University Of Cincinnati |
Method of using melanocyte stimulating hormone as dermatis treatment
|
|
US5275823A
(en)
|
1989-04-27 |
1994-01-04 |
Smith Kline & French Laboratories Ltd. |
Pharmaceutical compositions
|
|
DE3930696A1
(de)
|
1989-09-14 |
1991-03-28 |
Hoechst Ag |
Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel
|
|
US4997665A
(en)
|
1989-10-05 |
1991-03-05 |
Michigan Biotechnology Institute |
Dietary fibers and a process for their production
|
|
FR2661676A1
(fr)
|
1990-05-02 |
1991-11-08 |
Lipha |
Derives d'amino benzocycloalcanes, procedes de preparation et medicaments les contenant.
|
|
NZ240846A
(en)
|
1990-12-06 |
1994-04-27 |
Hoechst Ag |
Dimeric bile acid derivatives; preparatory processes and pharmaceutical compositions
|
|
WO1992018462A1
(en)
|
1991-04-12 |
1992-10-29 |
Schering Corporation |
Bicyclic amides as inhibitors of acyl-coenzyme a: cholesterol acyl transferase
|
|
IT1245890B
(it)
|
1991-04-12 |
1994-10-25 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
|
|
ATE139990T1
(de)
|
1991-10-17 |
1996-07-15 |
Shionogi & Co |
Lignan-analoge, ihre herstellung und hypolipidemische arzneimittel
|
|
AU653658B2
(en)
|
1991-12-20 |
1994-10-06 |
Hoechst Aktiengesellschaft |
Polymers and oligomers of bile acid derivatives, process for their preparation and their use as pharmaceuticals
|
|
GB9203347D0
(en)
|
1992-02-17 |
1992-04-01 |
Wellcome Found |
Hypolipidaemic compounds
|
|
DK0573848T3
(da)
|
1992-06-12 |
1998-08-10 |
Hoechst Ag |
Galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler
|
|
US5415872A
(en)
|
1992-06-22 |
1995-05-16 |
Digestive Care Inc. |
Compositions of gastric acid-resistant microspheres containing salts of bile acids
|
|
FR2698873B1
(fr)
|
1992-12-07 |
1995-02-24 |
Lipha |
Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.
|
|
IL108633A
(en)
|
1993-02-15 |
1998-07-15 |
Wellcome Found |
History of Benzothiazepine Hypolipidemic Preparation and Pharmaceutical Preparations Containing Them
|
|
IL108634A0
(en)
|
1993-02-15 |
1994-05-30 |
Wellcome Found |
Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them
|
|
US5594001A
(en)
|
1993-04-08 |
1997-01-14 |
The Dupont Merck Pharmaceutical Company |
Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders
|
|
DE69411243T2
(de)
|
1993-04-16 |
1998-11-19 |
Shionogi & Co |
Verfahren zur herstellung eines lignan-derivats
|
|
DE4314583A1
(de)
|
1993-04-29 |
1994-11-03 |
Astra Chem Gmbh |
Colestyramin enthaltende Zusammensetzung und Verfahren zu deren Herstellung
|
|
TW289021B
(enExample)
|
1993-05-08 |
1996-10-21 |
Hoechst Ag |
|
|
TW289020B
(enExample)
|
1993-05-08 |
1996-10-21 |
Hoechst Sktiengesellschaft |
|
|
EP0624593A3
(de)
|
1993-05-08 |
1995-06-07 |
Hoechst Ag |
Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel.
|
|
US5607669A
(en)
|
1994-06-10 |
1997-03-04 |
Geltex Pharmaceuticals, Inc. |
Amine polymer sequestrant and method of cholesterol depletion
|
|
DK0640344T3
(da)
|
1993-08-30 |
1999-07-05 |
Medichemie Ag |
Ursodesoxycholsyreholdigt lægemiddel i flydende administreringsform
|
|
US5589358A
(en)
|
1993-12-29 |
1996-12-31 |
Univ Wake Forest |
Ileal bile acid transporter compositions and methods
|
|
US5491152A
(en)
|
1994-03-23 |
1996-02-13 |
The Du Pont Merck Pharmaceutical Company |
Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis
|
|
TW474813B
(en)
|
1994-06-10 |
2002-02-01 |
Geltex Pharma Inc |
Alkylated composition for removing bile salts from a patient
|
|
KR970005178Y1
(ko)
|
1994-07-06 |
1997-05-24 |
김상수 |
개량형 노통연관 보일러
|
|
ZA956647B
(en)
|
1994-08-10 |
1997-02-10 |
Wellcome Found |
Hypolipidaemic compounds.
|
|
US6268392B1
(en)
|
1994-09-13 |
2001-07-31 |
G. D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
|
|
US5994391A
(en)
|
1994-09-13 |
1999-11-30 |
G.D. Searle And Company |
Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
US6262277B1
(en)
|
1994-09-13 |
2001-07-17 |
G.D. Searle And Company |
Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
BR9508916A
(pt)
|
1994-09-13 |
1997-12-30 |
Monsanto Co |
"Novas benzotiepinas tendo atividade como inibidores de transporte do ácido biliar ileal e absorção de taurocolato"
|
|
US6642268B2
(en)
|
1994-09-13 |
2003-11-04 |
G.D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
|
|
US6107494A
(en)
|
1994-09-13 |
2000-08-22 |
G.D. Searle And Company |
Substituted 5-aryl-benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
US5547975A
(en)
|
1994-09-20 |
1996-08-20 |
Talley; John J. |
Benzopyranopyrazolyl derivatives for the treatment of inflammation
|
|
US6034118A
(en)
|
1994-11-04 |
2000-03-07 |
Gilead Sciences, Inc. |
Thiepane compounds
|
|
GB9423172D0
(en)
|
1994-11-17 |
1995-01-04 |
Wellcom Foundation The Limited |
Hypolipidemic benzothiazepines
|
|
US5721103A
(en)
|
1994-12-30 |
1998-02-24 |
Ligand Pharmaceuticals Incorporated |
Trienoic retinoid compounds and methods
|
|
US6861053B1
(en)
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
|
TW438587B
(en)
|
1995-06-20 |
2001-06-07 |
Takeda Chemical Industries Ltd |
A pharmaceutical composition for prophylaxis and treatment of diabetes
|
|
US5886016A
(en)
|
1995-09-15 |
1999-03-23 |
G.D. Searle & Co. |
Benzopyranopyrazolyl derivatives for the treatment of inflammation
|
|
CN1217656C
(zh)
|
1995-11-02 |
2005-09-07 |
沃尼尔·朗伯公司 |
用于调节脂浓度的方法和药物组合物
|
|
US6069167A
(en)
|
1996-01-16 |
2000-05-30 |
University Technology Corporation |
Use of antioxidant agents to treat cholestatic liver disease
|
|
GB9601697D0
(en)
|
1996-01-27 |
1996-03-27 |
Pfizer Ltd |
Therapeutic agents
|
|
NZ331813A
(en)
|
1996-03-11 |
2001-03-30 |
G |
Benzothiepine compounds having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
DE122010000020I1
(de)
|
1996-04-25 |
2010-07-08 |
Prosidion Ltd |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
|
WO1998007749A1
(en)
|
1996-08-23 |
1998-02-26 |
Human Genome Sciences, Inc. |
Novel human growth factors
|
|
JPH1072371A
(ja)
|
1996-08-28 |
1998-03-17 |
Sankyo Co Ltd |
回腸型胆汁酸トランスポーター阻害剤
|
|
US6251852B1
(en)
|
1996-09-18 |
2001-06-26 |
Merck & Co., Inc. |
Combination therapy for reducing the risks associated with cardiovascular disease
|
|
US5908830A
(en)
|
1996-10-31 |
1999-06-01 |
Merck & Co., Inc. |
Combination therapy for the treatment of diabetes and obesity
|
|
GB9704208D0
(en)
|
1997-02-28 |
1997-04-16 |
Glaxo Group Ltd |
Chemical compounds
|
|
NZ337830A
(en)
|
1997-03-11 |
2001-07-27 |
G |
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
|
|
DK0864582T3
(da)
|
1997-03-14 |
2003-09-29 |
Aventis Pharma Gmbh |
Hypolidemiske 1,4-benzothiazepin-1,1-dioxider
|
|
ATE268758T1
(de)
|
1997-04-04 |
2004-06-15 |
Aventis Pharma Gmbh |
Hypolipidämische propanolaminderivate
|
|
DE19845402B4
(de)
|
1998-10-02 |
2005-04-07 |
Aventis Pharma Deutschland Gmbh |
Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
|
IT1292092B1
(it)
|
1997-06-05 |
1999-01-25 |
Geange Ltd |
Impiego di derivati eterociclici aromatici azotati nel trattamento topico di affezioni di tessuti epiteliali
|
|
AU7552198A
(en)
|
1997-06-11 |
1998-12-30 |
Sankyo Company Limited |
Benzylamine derivatives
|
|
GB9714274D0
(en)
|
1997-07-08 |
1997-09-10 |
Zeneca Ltd |
Pharmaceutical composition
|
|
US6180660B1
(en)
|
1997-08-26 |
2001-01-30 |
Merck & Co., Inc. |
Cholesterol-lowering therapy
|
|
US6066336A
(en)
|
1997-09-29 |
2000-05-23 |
Bristol-Myers Squibb Company |
Cholesterol-lowering tablets
|
|
US5900233A
(en)
|
1997-10-16 |
1999-05-04 |
Day; Charles E. |
Epichlorohydrin and 1-(3-aminopropyl) imidazole copolymer and its use in treating irritable bowel syndrome
|
|
US6245797B1
(en)
|
1997-10-22 |
2001-06-12 |
Merck & Co., Inc. |
Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
|
|
US6083497A
(en)
|
1997-11-05 |
2000-07-04 |
Geltex Pharmaceuticals, Inc. |
Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
|
|
DE19755480A1
(de)
|
1997-12-13 |
1999-06-24 |
Gruenenthal Gmbh |
Substituierte heterocyclische Benzocycloalkene und ihre Verwendung als analgetisch wirksame Substanzen
|
|
KR20010015884A
(ko)
|
1997-12-19 |
2001-02-26 |
윌리암스 로저 에이 |
거울상이성질체적으로 풍부한 테트라히드로벤조티에핀옥시드의 제조방법
|
|
GB9800428D0
(en)
|
1998-01-10 |
1998-03-04 |
Glaxo Group Ltd |
Chemical compounds
|
|
EP2823812A1
(en)
|
1998-02-02 |
2015-01-14 |
Trustees Of Tufts College |
Dipeptidylpeptidase IV inhibitors for use in the treatment of Type II diabetes
|
|
US6221897B1
(en)
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
|
DE19825804C2
(de)
|
1998-06-10 |
2000-08-24 |
Aventis Pharma Gmbh |
1,4-Benzothiepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
JP2000026300A
(ja)
|
1998-07-02 |
2000-01-25 |
Pola Chem Ind Inc |
血管内皮細胞保護医薬組成物
|
|
AU5194999A
(en)
|
1998-08-07 |
2000-02-28 |
Takeda Chemical Industries Ltd. |
Benzothiepin derivatives, process for the preparation of the same and uses thereof
|
|
AU5301599A
(en)
|
1998-08-20 |
2000-03-14 |
Takeda Chemical Industries Ltd. |
Quaternary ammonium salts and their use
|
|
DE19845405C2
(de)
|
1998-10-02 |
2000-07-13 |
Aventis Pharma Gmbh |
Arylsubstituierte Propanolaminderivate und deren Verwendung
|
|
DE19845403B4
(de)
|
1998-10-02 |
2005-02-10 |
Aventis Pharma Deutschland Gmbh |
Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
|
DE19845406C2
(de)
|
1998-10-02 |
2001-10-18 |
Aventis Pharma Gmbh |
Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
|
AU1684400A
(en)
|
1998-12-11 |
2000-07-03 |
Sankyo Company Limited |
Substituted benzylamines
|
|
AU1690100A
(en)
|
1998-12-21 |
2000-07-12 |
Takeda Chemical Industries Ltd. |
Benzothiepin-anilide derivatives, their production and their use for antagonizing ccr-5
|
|
MXPA01006472A
(es)
|
1998-12-23 |
2004-03-10 |
Searle Llc |
Combinaciones de inhibidores de transporte de acido biliar ileal y derivados de acido fibrico para indicaciones cardiovasculares.
|
|
CN1342091A
(zh)
|
1998-12-23 |
2002-03-27 |
G.D.瑟尔有限公司 |
心血管指征的联合用药
|
|
EP1342475A1
(en)
|
1998-12-23 |
2003-09-10 |
G.D. Searle LLC. |
Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
|
|
PT1140190E
(pt)
|
1998-12-23 |
2003-02-28 |
Searle Llc |
Combinacoes de inibidores do transporte ileal dos acidos biliares e agentes sequestrantes dos acidos biliares usadas para problemas cardiovasculares
|
|
CA2362147A1
(en)
|
1999-02-12 |
2000-08-17 |
Steve A. Kolodziej |
1,2-benzothiazepines for the treatment of hyperlipidemic diseases
|
|
DE19916108C1
(de)
|
1999-04-09 |
2001-01-11 |
Aventis Pharma Gmbh |
Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
|
SE9901387D0
(sv)
*
|
1999-04-19 |
1999-04-19 |
Astra Ab |
New pharmaceutical foromaulations
|
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
|
CZ290178B6
(cs)
|
1999-07-22 |
2002-06-12 |
Sankyo Company Limited |
Deriváty cyklobutenu
|
|
WO2001020331A1
(en)
|
1999-09-14 |
2001-03-22 |
Xenoport, Inc. |
Substrates and screening methods for transport proteins
|
|
AU1302301A
(en)
|
1999-11-08 |
2001-06-06 |
Sankyo Company Limited |
Nitrogenous heterocycle derivatives
|
|
AU3104301A
(en)
*
|
2000-01-20 |
2001-07-31 |
Noven Pharmaceuticals, Inc. |
Compositions and methods to effect the release profile in the transdermal administration of active agents
|
|
DK1248604T4
(da)
|
2000-01-21 |
2012-05-21 |
Novartis Ag |
Kombinationer indeholdende dipeptidylpeptidase-IV-inhibitorer og antidiabetiske midler
|
|
SE0000772D0
(sv)
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2001068096A2
(en)
|
2000-03-10 |
2001-09-20 |
Pharmacia Corporation |
Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
|
|
EP1286984A2
(en)
|
2000-03-10 |
2003-03-05 |
Pharmacia Corporation |
Method for the preparation of tetrahydrobenzothiepines
|
|
WO2001077325A1
(fr)
|
2000-04-12 |
2001-10-18 |
Takeda Chemical Industries, Ltd. |
Nouvelle proteine de recepteur couple aux proteines g et adn de celle-ci
|
|
US20020183307A1
(en)
|
2000-07-26 |
2002-12-05 |
Tremont Samuel J. |
Novel 1,4-benzothiazephine and 1,5-benzothiazepine compounds as inhibitors of apical sodium co-dependent bile acid transport and taurocholate uptake
|
|
CN100423715C
(zh)
|
2000-07-28 |
2008-10-08 |
霍夫曼-拉罗奇有限公司 |
新型药物组合物
|
|
SE0003766D0
(sv)
|
2000-10-18 |
2000-10-18 |
Astrazeneca Ab |
Novel formulation
|
|
JP4003069B2
(ja)
|
2000-11-17 |
2007-11-07 |
萬有製薬株式会社 |
新規なグアノシン三リン酸（ｇｔｐ）結合タンパク質共役型のレセプタータンパク質、ｂｇ３７
|
|
EG26979A
(en)
|
2000-12-21 |
2015-03-01 |
Astrazeneca Ab |
Chemical compounds
|
|
HUP0401081A3
(en)
|
2000-12-21 |
2010-06-28 |
Sanofi Aventis Deutschland |
Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and their use
|
|
IL156488A0
(en)
|
2001-01-26 |
2004-01-04 |
Schering Corp |
Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
|
|
WO2002078625A2
(en)
|
2001-03-28 |
2002-10-10 |
Pharmacia Corporation |
Therapeutic combinations for cardiovascular and inflammatory indications
|
|
ATE363917T1
(de)
|
2001-07-19 |
2007-06-15 |
Pharmacia Corp |
Kombination von einem aldosterone rezeptor antagonisten und einem hmg coa reduktase hemmer
|
|
BR0212031A
(pt)
|
2001-08-22 |
2004-08-03 |
Aventis Pharma Gmbh |
Preparados de combinação de derivados de 1,1-dióxido de 1-4-benzotiepina com outras substâncias ativas e seu emprego
|
|
GB0121337D0
(en)
|
2001-09-04 |
2001-10-24 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0121621D0
(en)
|
2001-09-07 |
2001-10-31 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0121622D0
(en)
|
2001-09-07 |
2001-10-31 |
Astrazeneca Ab |
Chemical compounds
|
|
PL216023B1
(pl)
|
2001-09-08 |
2014-02-28 |
Astrazeneca Ab |
Pochodna benzotiadiazepiny, kompozycja farmaceutyczna zawierajaca pochodna benzotiadiazepiny oraz zastosowania pochodnej benzotiadiazepiny
|
|
WO2003022861A1
(en)
|
2001-09-13 |
2003-03-20 |
Bristol-Myers Squibb Company |
Process for the preparation of rebeccamycin and analogs thereof
|
|
EP1429756B1
(en)
|
2001-09-21 |
2006-11-22 |
Schering Corporation |
Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
|
|
CA2462455C
(en)
|
2001-10-01 |
2012-07-17 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Development of a preventive vaccine for filovirus infection in primates
|
|
US6740663B2
(en)
|
2001-11-02 |
2004-05-25 |
G.D. Searle, Llc |
Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
|
|
AU2003207431A1
(en)
|
2002-01-17 |
2003-09-02 |
Pharmacia Corporation |
Novel alkyl/aryl hydroxy or keto thiepines.
|
|
GB0201850D0
(en)
|
2002-01-26 |
2002-03-13 |
Astrazeneca Ab |
Therapeutic treatment
|
|
US20040014806A1
(en)
|
2002-03-08 |
2004-01-22 |
Pharmacia Corporation |
Methods and compositions for lowering levels of blood lipids
|
|
GB0209467D0
(en)
|
2002-04-25 |
2002-06-05 |
Astrazeneca Ab |
Chemical compounds
|
|
US6987121B2
(en)
*
|
2002-04-25 |
2006-01-17 |
Smithkline Beecham Corporation |
Compositions and methods for hepatoprotection and treatment of cholestasis
|
|
WO2003099264A1
(en)
|
2002-05-23 |
2003-12-04 |
Umd, Inc. |
Compositions and method for transmucosal drug delivery and cryoprotection
|
|
GB0213669D0
(en)
|
2002-06-14 |
2002-07-24 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0215579D0
(en)
|
2002-07-05 |
2002-08-14 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0216321D0
(en)
|
2002-07-13 |
2002-08-21 |
Astrazeneca Ab |
Therapeutic treatment
|
|
CN100494185C
(zh)
|
2002-08-28 |
2009-06-03 |
旭化成制药株式会社 |
新型季铵化合物
|
|
US7312208B2
(en)
*
|
2002-08-28 |
2007-12-25 |
Asahi Kasei Pharma Corporation |
Quaternary ammonium compounds
|
|
JP2006508188A
(ja)
|
2002-11-06 |
2006-03-09 |
シェーリング コーポレイション |
脱髄の処置のためのコレステロール吸収インヒビター
|
|
US20040122033A1
(en)
|
2002-12-10 |
2004-06-24 |
Nargund Ravi P. |
Combination therapy for the treatment of obesity
|
|
FR2848452B1
(fr)
*
|
2002-12-12 |
2007-04-06 |
Aventis Pharma Sa |
Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer
|
|
US20040138145A1
(en)
|
2002-12-12 |
2004-07-15 |
Aventis Pharma S.A. |
Application of intestinal biliary acid reuptake inhibitors for the prevention and treatment of alzheimer's disease
|
|
US20040147774A1
(en)
|
2002-12-20 |
2004-07-29 |
Aventis Pharma S.A. |
Novel chiral compounds derived from hexanoic acid esters, preparation process and intermediates, use in the synthesis of chiral 2-(bromomethyl)-2-ethylhexanoic acid
|
|
US20050031651A1
(en)
|
2002-12-24 |
2005-02-10 |
Francine Gervais |
Therapeutic formulations for the treatment of beta-amyloid related diseases
|
|
GB0304194D0
(en)
|
2003-02-25 |
2003-03-26 |
Astrazeneca Ab |
Chemical compounds
|
|
CN1756755A
(zh)
|
2003-03-07 |
2006-04-05 |
先灵公司 |
取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
|
|
CN1756756A
(zh)
|
2003-03-07 |
2006-04-05 |
先灵公司 |
取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
|
|
GB0307918D0
(en)
|
2003-04-05 |
2003-05-14 |
Astrazeneca Ab |
Therapeutic use
|
|
JP2005044778A
(ja)
|
2003-07-19 |
2005-02-17 |
Samsung Sdi Co Ltd |
電界発光素子
|
|
JP2005097216A
(ja)
|
2003-09-26 |
2005-04-14 |
Kaneka Corp |
ＰＰＡＲγリガンド剤
|
|
JP2007510659A
(ja)
|
2003-11-05 |
2007-04-26 |
シェーリング コーポレイション |
脂質調節剤および置換アゼチジノンの組み合わせならびに血管状態の処置
|
|
EP1564554A1
(en)
|
2004-02-12 |
2005-08-17 |
Pepscan Systems B.V. |
Method for the detection of early B cell populations in vaccine development
|
|
KR20070026392A
(ko)
*
|
2004-02-27 |
2007-03-08 |
아사히 가세이 파마 가부시키가이샤 |
신규 벤조티아제핀 및 벤조티에핀 화합물
|
|
DE102004016845A1
(de)
|
2004-04-07 |
2005-10-27 |
Bayer Healthcare Ag |
Phenylthioessigsäure-Derivate und ihre Verwendung
|
|
WO2006017257A2
(en)
|
2004-07-12 |
2006-02-16 |
Phenomix Corporation |
Azetidinone derivatives
|
|
EP1799263A4
(en)
|
2004-09-15 |
2009-07-29 |
Harvard College |
REDUCTION OF ER-STRESS IN THE TREATMENT OF ADIPOSITAS AND DIABETES
|
|
DE102004046623A1
(de)
|
2004-09-25 |
2006-03-30 |
Bayer Healthcare Ag |
Neue Pyrimidin-Derivate und ihre Verwendung
|
|
JP2008514718A
(ja)
|
2004-09-29 |
2008-05-08 |
シェーリング コーポレイション |
置換アゼチドノンおよびｃｂ１アンタゴニストの組み合わせ
|
|
EP1810689A4
(en)
|
2004-10-15 |
2009-07-22 |
Mitsubishi Tanabe Pharma Corp |
MEANS FOR THE PREVENTION AND / OR TREATMENT OF DIABETES
|
|
EP1807066A1
(en)
|
2004-10-25 |
2007-07-18 |
Novartis AG |
Combination of dpp-iv inhibitor, ppar antidiabetic and metformin
|
|
JP2008521800A
(ja)
|
2004-11-24 |
2008-06-26 |
セオ ホン ユー |
水可溶化胆汁酸投薬処方の乾燥形態、その製造方法及び用途
|
|
DE102004058062A1
(de)
|
2004-12-02 |
2006-06-08 |
Bayer Healthcare Ag |
Cyclische Iminocarbamate und ihre Verwendung
|
|
WO2006060461A1
(en)
|
2004-12-03 |
2006-06-08 |
Schering Corporation |
Substituted piperazines as cb1 antagonists
|
|
WO2006086727A2
(en)
|
2005-02-09 |
2006-08-17 |
Entelos, Inc. |
Treating diabetes with glucagon-like peptide-1 secretagogues
|
|
US20060193895A1
(en)
|
2005-02-25 |
2006-08-31 |
Use-Techno Corporation |
Additive for food and beverage, pharmaceutical composition, GLUT4 translocator, and method for translocating GLUT4
|
|
DE102005027150A1
(de)
|
2005-03-12 |
2006-09-28 |
Bayer Healthcare Ag |
Pyrimidincarbonsäure-Derivate und ihre Verwendung
|
|
FR2883284A1
(fr)
|
2005-03-15 |
2006-09-22 |
Commissariat Energie Atomique |
Nouveaux derives dihydropyrimidines et leur utilisation comme agents anti-cancereux
|
|
PE20061245A1
(es)
|
2005-03-30 |
2007-01-06 |
Generex Pharm Inc |
Composiciones para la transmision transmucosa oral de la metformina
|
|
US20080031968A1
(en)
|
2005-04-01 |
2008-02-07 |
The Brigham And Women's Hospital, Inc. |
Methods for increasing cellular energy expenditure
|
|
WO2006105913A1
(en)
|
2005-04-04 |
2006-10-12 |
Julius-Maximillians-Universität Würzburg |
Tripeptides that down regulate the activity of plasma membrane transporters including sodium-d-glucose cotransporter sglt1
|
|
US8207133B1
(en)
|
2005-04-04 |
2012-06-26 |
Julius-Maximilians-Universitat Wurzburg |
Peptides that down regulate the activity of plasma membrane transporters including sodium-D-glucose cotransporter SGLT1
|
|
JP2008539255A
(ja)
|
2005-04-26 |
2008-11-13 |
マイクロビア インコーポレーテッド |
高コレステロール血症のための４−ビアリーリル−１−フェニルアゼチジン−２−オングルクロニド誘導体
|
|
DE102005020229A1
(de)
|
2005-04-30 |
2006-11-09 |
Bayer Healthcare Ag |
Verwendung von Indolin-Phenylsulfonamid-Derivaten
|
|
WO2006116814A1
(en)
|
2005-05-02 |
2006-11-09 |
Vanadis Bioscience Ltd |
Composition and uses thereof
|
|
WO2006121861A2
(en)
|
2005-05-05 |
2006-11-16 |
Microbia, Inc. |
Biphenylazetidinone cholesterol absorption inhibitors
|
|
WO2006122186A2
(en)
|
2005-05-10 |
2006-11-16 |
Microbia, Inc. |
1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia
|
|
JP2008540573A
(ja)
|
2005-05-13 |
2008-11-20 |
マイクロビア インコーポレーテッド |
４−ビアリーリル−１−フェニラゼチジン−２−オン類
|
|
MX2007015085A
(es)
*
|
2005-05-31 |
2008-01-17 |
Novartis Ag |
Tratamiento de enfermedades del higado en donde el hierro juega un papel importante en patogenesis.
|
|
DE102005033099A1
(de)
|
2005-07-15 |
2007-01-18 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindung enthaltende Arzneimittel und dessen Verwendung
|
|
US20070025953A1
(en)
|
2005-07-27 |
2007-02-01 |
Jones Michael R |
Co-therapy for diabetic conditions
|
|
US7332604B2
(en)
|
2005-09-20 |
2008-02-19 |
Schering Corporation |
1-[[1-[(2-Amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbonyl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-b]pyridin-3-yl]piperidine
|
|
RU2008116578A
(ru)
|
2005-09-30 |
2009-11-10 |
Новартис АГ (CH) |
Применение ингибиторов dpp-iv для лечения аутоиммунных заболеваний и отторжения трансплантата
|
|
WO2007050628A2
(en)
|
2005-10-24 |
2007-05-03 |
Andrew Young |
Biliary/pancreatic shunt device and method for treatment of metabolic and other diseases
|
|
WO2007076260A2
(en)
|
2005-12-19 |
2007-07-05 |
Smithkline Beecham Corporation |
Farnesoid x receptor agonists
|
|
CA2634940A1
(en)
|
2005-12-21 |
2007-07-05 |
Schering Corporation |
Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and h3 receptor antagonist/inverse agonist
|
|
WO2007084319A2
(en)
|
2006-01-13 |
2007-07-26 |
Schering Corporation |
Diaryl piperidines as cb1 modulators
|
|
BRPI0706623A2
(pt)
|
2006-01-18 |
2011-04-12 |
Schering Corp |
moduladores de receptor canabinóide
|
|
EA200801551A1
(ru)
|
2006-01-20 |
2009-02-27 |
Смитклайн Бичем Корпорейшн |
Применение сульфонамидных производных в лечении расстройств метаболизма и нервной системы
|
|
WO2007095174A2
(en)
|
2006-02-14 |
2007-08-23 |
Intercept Pharmaceuticals, Inc. |
Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions
|
|
DE102006009813A1
(de)
|
2006-03-01 |
2007-09-06 |
Bayer Healthcare Ag |
Verwendung von A2b/A1 Rezeptor Agonisten zur Modulation der Lipidspiegel
|
|
US20070254952A1
(en)
|
2006-04-21 |
2007-11-01 |
Yuguang Wang |
Cannabinoid receptor modulators
|
|
DE102006024024A1
(de)
|
2006-05-23 |
2007-11-29 |
Bayer Healthcare Aktiengesellschaft |
Substituierte Arylimidazolone und -triazolone sowie ihre Verwendung
|
|
DE102006026583A1
(de)
|
2006-06-07 |
2007-12-13 |
Bayer Healthcare Aktiengesellschaft |
Aryl-substituierte hetero-bicyclische Verbindungen und ihre Verwendung
|
|
DE102006026585A1
(de)
|
2006-06-07 |
2007-12-13 |
Bayer Healthcare Aktiengesellschaft |
Substituierte 4-Aryl-1,4-dihydro-1,6-naphthyridine und ihre Verwendung
|
|
CN101522703B
(zh)
|
2006-06-27 |
2013-04-17 |
英特塞普特医药品公司 |
胆酸派生物及其在制备预防或治疗fxr介导的疾病或状况的药物中的应用
|
|
US20080065136A1
(en)
|
2006-08-30 |
2008-03-13 |
Andrew Young |
Distender device and method for treatment of obesity and metabolic and other diseases
|
|
DE102006042143A1
(de)
|
2006-09-08 |
2008-03-27 |
Bayer Healthcare Aktiengesellschaft |
Neue substituierte Bipyridin-Derivate und ihre Verwendung
|
|
DE102006043520A1
(de)
|
2006-09-12 |
2008-03-27 |
Bayer Healthcare Ag |
2-Phenoxynikotinsäure-Derivate und ihre Verwendung
|
|
DE102006043519A1
(de)
|
2006-09-12 |
2008-03-27 |
Bayer Healthcare Ag |
4-Phenoxynikotinsäure-Derivate und ihre Verwendung
|
|
US20080070890A1
(en)
|
2006-09-15 |
2008-03-20 |
Burnett Duane A |
Spirocyclic Azetidinone Compounds and Methods of Use Thereof
|
|
JP2010503673A
(ja)
|
2006-09-15 |
2010-02-04 |
シェーリング コーポレイション |
疼痛および脂質代謝障害を処置する際に有用なアゼチジン誘導体およびアゼチドン誘導体
|
|
JP2010503676A
(ja)
|
2006-09-15 |
2010-02-04 |
シェーリング コーポレイション |
疼痛、糖尿病および脂質代謝の障害の治療
|
|
US20080070984A1
(en)
|
2006-09-15 |
2008-03-20 |
Tran Pierre V |
Compositions and Methods of Treating Schizophrenia
|
|
CA2663503A1
(en)
|
2006-09-15 |
2008-03-20 |
Schering Corporation |
Azetidinone derivatives and methods of use thereof
|
|
MX2009002921A
(es)
|
2006-09-15 |
2009-04-01 |
Schering Corp |
Derivados de azetidinona para el tratamiento de trastornos del metabolismo lipidico.
|
|
CN101541805A
(zh)
|
2006-09-15 |
2009-09-23 |
先灵公司 |
用于治疗疼痛和脂代射紊乱的氮杂环丁烷和氮杂环丁酮衍生物
|
|
CA2663500A1
(en)
|
2006-09-15 |
2008-03-20 |
Schering Corporation |
Spiro-condensed azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism
|
|
DE102006044696A1
(de)
|
2006-09-22 |
2008-03-27 |
Bayer Healthcare Ag |
3-Cyano-5-thiazaheteroaryl-dihydropyridine und ihre Verwendung
|
|
WO2008039829A2
(en)
|
2006-09-26 |
2008-04-03 |
Ironwood Pharmaceuticals, Inc. |
Diphenylheterocycle cholesterol absorption inhibitors
|
|
CL2007003035A1
(es)
|
2006-10-24 |
2008-05-16 |
Smithkline Beechman Corp |
Compuestos derivados de isoxazol sustituidos, agonistas de receptores farnesoid x; procedimiento de preparacion; composicion farmaceutica que lo comprende; y uso del compuesto en el tratamiento de la obesidad, diabetes mellitus, fibrosis en organos,
|
|
US20080161400A1
(en)
|
2006-10-26 |
2008-07-03 |
Xenoport, Inc. |
Use of forms of propofol for treating diseases associated with oxidative stress
|
|
DE102006053635B4
(de)
|
2006-11-14 |
2011-06-30 |
Sanofi-Aventis Deutschland GmbH, 65929 |
Neue mit Benzylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
|
WO2008058631A1
(de)
|
2006-11-14 |
2008-05-22 |
Sanofi-Aventis Deutschland Gmbh |
Neue 1,4-benzothiepin-1,1-dioxidderivate mit verbesserten eigenschaften, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
DE102006053637B4
(de)
*
|
2006-11-14 |
2011-06-30 |
Sanofi-Aventis Deutschland GmbH, 65929 |
Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
|
US20090035306A1
(en)
|
2006-11-29 |
2009-02-05 |
Kalypsys, Inc. |
Quinazolinone modulators of tgr5
|
|
DE102006056740A1
(de)
|
2006-12-01 |
2008-06-05 |
Bayer Healthcare Ag |
Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung
|
|
DE102006056739A1
(de)
|
2006-12-01 |
2008-06-05 |
Bayer Healthcare Ag |
Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung
|
|
US20090074785A1
(en)
|
2007-01-16 |
2009-03-19 |
Smith Jeffrey W |
Compositions and methods for treatment of colorectal cancer
|
|
JP5292310B2
(ja)
|
2007-01-19 |
2013-09-18 |
インターセプト ファーマシューティカルズ， インコーポレイテッド |
Ｔｇｒ５調節剤としての２３−置換胆汁酸およびその使用方法
|
|
WO2008097976A1
(en)
|
2007-02-09 |
2008-08-14 |
Kalypsys, Inc. |
Heterocyclic modulators of tgr5 for treatment of disease
|
|
DE102007009494A1
(de)
|
2007-02-27 |
2008-08-28 |
Bayer Healthcare Ag |
Substituierte 4-Aryl-1, 4-dihydro-1,6-naphthyridinamide und ihre Verwendung
|
|
WO2008124505A2
(en)
|
2007-04-05 |
2008-10-16 |
Ironwood Pharmaceuticals,Inc. |
Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders
|
|
US20100197564A1
(en)
|
2007-04-19 |
2010-08-05 |
Schering Corporation |
Diaryl morpholines as cb1 modulators
|
|
WO2009026537A1
(en)
|
2007-08-23 |
2009-02-26 |
Theracos, Inc. |
Benzylbenzene derivatives and methods of use
|
|
WO2009115398A1
(en)
*
|
2008-03-18 |
2009-09-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Vitamin d compounds for the treatment of biliary diseases
|
|
EP2146210A1
(en)
|
2008-04-07 |
2010-01-20 |
Arena Pharmaceuticals, Inc. |
Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
|
|
EA020310B1
(ru)
|
2008-07-30 |
2014-10-30 |
Интерсепт Фармасьютикалз, Инк. |
Модуляторы рецептора tgr5 и их применение
|
|
ES2663948T3
(es)
|
2008-11-19 |
2018-04-17 |
Intercept Pharmaceuticals, Inc. |
Moduladores de TGR5 y método de uso de los mismos
|
|
EP2367554A4
(en)
*
|
2008-11-26 |
2020-03-25 |
Satiogen Pharmaceuticals, Inc. |
Bile acid reflux inhibitor for the treatment of obesity and diabetes
|
|
JP2012509892A
(ja)
|
2008-11-26 |
2012-04-26 |
サティオゲン ファーマシューティカルズ，インク． |
サティオゲン類を含有する組成物及び使用の方法
|
|
US20110065676A1
(en)
|
2009-06-24 |
2011-03-17 |
Schering Corporation |
Combination therapies comprising par1 antagonists with nar agonists
|
|
JP5909774B2
(ja)
|
2009-08-25 |
2016-04-27 |
クィン ビル セラピューティクス インコーポレイテッド |
胆道疾患を治療するためのポリヒドロキシル化胆汁酸
|
|
US20110152204A1
(en)
*
|
2009-12-18 |
2011-06-23 |
Satiogen Pharmaceuticals, Inc. |
Treatment of Obesity or Diabetes with Bile Acid Sequestrants
|
|
EP3593802A3
(en)
*
|
2010-05-26 |
2020-03-25 |
Satiogen Pharmaceuticals, Inc. |
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
|
|
ES2586931T3
(es)
|
2010-11-04 |
2016-10-19 |
Albireo Ab |
Inhibidores de IBAT para el tratamiento de enfermedades hepáticas
|
|
RU2619215C2
(ru)
|
2010-11-08 |
2017-05-12 |
Альбирео Аб |
Фармацевтическая комбинация, включающая ibat-ингибитор и связующее желчной кислоты
|
|
US20120114588A1
(en)
|
2010-11-08 |
2012-05-10 |
Albireo Ab |
Ibat inhibitors for treatment of metabolic disorders and related conditions
|
|
EP2637667A4
(en)
|
2010-11-08 |
2014-06-25 |
Albireo Ab |
IBAT HEMMER FOR THE TREATMENT OF METABOLISM DISEASES AND RELATED ACCIDENTS
|
|
BR112014010223B8
(pt)
|
2011-10-28 |
2021-02-23 |
Lumena Pharmaceuticals Llc |
uso de uma composição compreendendo inibidores de reciclagem de ácido de bílis e forma de dosagem pediátrica
|
|
KR102051031B1
(ko)
*
|
2011-10-28 |
2019-12-02 |
루메나 파마수티컬즈, 인코포레이티드 |
고담혈증 및 담즙 정체성 간 질환 치료용 담즙산 재순환 억제제
|
|
US9007272B2
(en)
|
2012-07-19 |
2015-04-14 |
Tensorcom, Inc. |
Method and apparatus for the alignment of a 60 GHz endfire antenna
|
|
EP2968230A2
(en)
|
2013-03-15 |
2016-01-20 |
Lumena Pharmaceuticals, Inc. |
Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
|
|
PT3435996T
(pt)
|
2016-03-31 |
2025-05-13 |
Genfit |
Elafibranor para utilização no tratamento de colangite biliar primária
|
|
CN110536683A
(zh)
|
2017-04-18 |
2019-12-03 |
基恩菲特公司 |
包含PPAR激动剂如伊拉非诺和乙酰CoA羧化酶ACC抑制剂的组合
|